Literature DB >> 30905798

Real-world drug usage survival of spironolactone versus oral antibiotics for the management of female patients with acne.

John S Barbieri1, Juliana K Choi2, William D James3, David J Margolis4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30905798      PMCID: PMC6698210          DOI: 10.1016/j.jaad.2019.03.036

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

1.  Frequency of Treatment Switching for Spironolactone Compared to Oral Tetracycline-Class Antibiotics for Women With Acne: A Retrospective Cohort Study 2010-2016.

Authors:  John S Barbieri; Juliana K Choi; Nandita Mitra; David J Margolis
Journal:  J Drugs Dermatol       Date:  2018-06-01       Impact factor: 2.114

2.  Trends in Oral Antibiotic Prescription in Dermatology, 2008 to 2016.

Authors:  John S Barbieri; Ketaki Bhate; Kathleen P Hartnett; Katherine E Fleming-Dutra; David J Margolis
Journal:  JAMA Dermatol       Date:  2019-03-01       Impact factor: 10.282

3.  The Use of Hormonal Antiandrogen Therapy in Female Patients with Acne: A 10-Year Retrospective Study.

Authors:  Joyce H Park; Amanda Bienenfeld; Seth J Orlow; Arielle R Nagler
Journal:  Am J Clin Dermatol       Date:  2018-06       Impact factor: 7.403

4.  The prevalence of acne in adults 20 years and older.

Authors:  Christin N Collier; Julie C Harper; Jennifer A Cafardi; Wendy C Cantrell; Wenquan Wang; K Wade Foster; Boni E Elewski
Journal:  J Am Acad Dermatol       Date:  2007-10-22       Impact factor: 11.527

Review 5.  Approaches to limit systemic antibiotic use in acne: Systemic alternatives, emerging topical therapies, dietary modification, and laser and light-based treatments.

Authors:  John S Barbieri; Natalie Spaccarelli; David J Margolis; William D James
Journal:  J Am Acad Dermatol       Date:  2018-10-05       Impact factor: 11.527

  5 in total
  1 in total

1.  Real-world adherence to topical therapies in patients with moderate acne.

Authors:  Xuân-Lan Lam Hoai; Viviane De Maertelaer; Thierry Simonart
Journal:  JAAD Int       Date:  2021-01-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.